The cell line derived from the patient with ovarian cancer (EpCAM-CK+) was characterized by flow cytometry for expression of different stem cells markers (additional file 1) and by Comparative Genomic Hybridization (CGH). Here, EPCAM is linked to ovarian carcinoma.